Clinical Trials Logo

Clinical Trial Summary

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of 50 mg NYX-783 Once Daily Compared to Placebo in Participants with Post-Traumatic Stress Disorder (PTSD)

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05181995
Study type Interventional
Source Aptinyx
Contact Aptinyx Clinical Development
Phone 847-871-0377
Email [email protected]
Status Recruiting
Phase Phase 2/Phase 3
Start date December 13, 2021
Completion date December 2023

See also
  Status Clinical Trial Phase
Recruiting NCT03962504 - Written Exposure Therapy Versus Prolonged Exposure: a Non-inferiority Trial N/A
Completed NCT01995123 - Behavioral Activation for Smoking Cessation in PTSD N/A
Recruiting NCT04597450 - Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD) Phase 1
Recruiting NCT03593772 - Mission Reconnect- Delivering a Mobile and Web Based Self Directed Complementary And Integrative Health Program to Veterans and Their Partners to Manage Pain and PTSD N/A
Recruiting NCT03429166 - Connecting Women to Care: Home-based Psychotherapy for Women With MST Living in Rural Areas N/A
Recruiting NCT04317820 - Deep Brain Reorienting in Post-traumatic Stress Disorder N/A
Recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT03504722 - Evaluating the Feasibility of RESCUE: An Adjunctive HAI-Based Intervention for Veterans With PTSD N/A
Completed NCT04305353 - Intensive Care Unit (ICU) Diary Project N/A
Recruiting NCT04924166 - PTSD Prevention Using Oral Hydrocortisone Phase 2
Completed NCT03113890 - McLean and Genomind Prospective Study N/A
Not yet recruiting NCT05011552 - Feasibility Study for Abused Chinese Immigrant Women N/A
Not yet recruiting NCT04985344 - Treatment of Pediatric Post-traumatic Stress Disorder With Memory Reactivation Under the Influence of Propranolol Phase 3
Withdrawn NCT03924297 - Chilipad for Sleep and Symptoms of PTSD N/A
Not yet recruiting NCT04056767 - Changes in Digital Phenotype During PE Therapy
Recruiting NCT03216356 - Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD Phase 2/Phase 3
Active, not recruiting NCT02884908 - Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD Phase 3
Completed NCT03343028 - Biomarker Establishment for Superior Treatment of PTSD
Completed NCT03158558 - Intensive Weekend Retreat Multi-Couple Group Therapy for PTSD N/A
Active, not recruiting NCT02370173 - A Non-Pharmacological Method for Enhancing Sleep in PTSD N/A